Severe Toxoplasmic Hepatitis in an Immunocompetent Patient

Japanese Journal of Infectious Diseases
Aynur AtillaS Sırrı Kiliç

Abstract

Acute Toxoplasma gondii infection causes different clinical courses in 10-20% of cases. In immunocompetent patients, toxoplasmosis most often presents as asymptomatic cervical lymphadenopathy. Clinical manifestations such as pneumonia, myocarditis, hepatitis, and encephalitis are rarely reported. We present the case of an immunocompetent patient with a serious and complicated clinical course of toxoplasmic hepatitis with a maculopapular rash. The diagnosis was confirmed by serology and identification of bradyzoites in liver biopsy samples.

References

Oct 28, 1967·Lancet·T L VischerE Engelbrecht
May 1, 1982·Postgraduate Medical Journal·I TiwariA W Popple
Jan 17, 1980·The New England Journal of Medicine·J Lieb
Nov 1, 2002·Journal of Clinical Microbiology·B CarmeM L Dardé
Jun 15, 2004·Lancet·J G Montoya, O Liesenfeld
Aug 18, 2004·Lancet·Philippe Bossi, François Bricaire
Feb 17, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Fabio Eudes LealEsper Georges Kallas

❮ Previous
Next ❯

Citations

May 17, 2011·Parasites & Vectors·Cosme Alvarado-EsquivelMiguel Francisco Mercado-Suarez
Sep 27, 2019·Parasitology·Z Kolören, J P Dubey
Dec 11, 2019·Infection·M MartinotF Vely
May 29, 2018·Case Reports in Infectious Diseases·Fernando De la Garza-SalazarAdrián Camacho-Ortiz
Feb 9, 2021·Frontiers in Microbiology·Idessania Nazareth CostaEloisa Amália Vieira Ferro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Revista Do Instituto De Medicina Tropical De São Paulo
Juan NunuraHilda Solis
The Journal of Eukaryotic Microbiology
L M WeissM Wittner
© 2021 Meta ULC. All rights reserved